1/ New review paper on LLM applications in neuroscience published in Neuron by the Mindstate Design Labs team & collaborators, led by our advisor Danilo Bzdok. LLMs are going to change the game in neuroscience & psychedelics. sciencedirect.com/science/articl…

"Neuroscientists today are literally 'drowning in information but starving for knowledge'’.’ A *brilliant* review for how large language model #AI is changing that, as biology becomes an engineering discipline cell.com/neuron/fulltex… Neuron Danilo Bzdok Siva Reddy

Dillan DiNardo, Mindstate Design Labs’s CEO, believes mental health will remain a top concern in 2024, with the intersection of AI and neuroscience potentially leading to groundbreaking advancements in understanding and addressing mental health challenges. Read more 2024 predictions

1/ We've filed the IND for our lead MSD-001, a formulation of 5-MeO-MiPT. 5-MeO-MiPT’s unique pharmacology & phenomenology make it the ideal “primer” for enabling the intentional design of conscious states with fixed-dose combination psychedelics. fiercebiotech.com/biotech/mindst…

Mindstate Design Labs has applied to the FDA for an IND to begin clinical trials for their lead drug candidate targeting the psychedelic compound 5-MeO-MiPT, also known as moxy. The company analyzed over 70,000 reports from people who used psychedelics to select this compound.

"Our mission at Mindstate is to...use those first-generation [psychedelic] compounds as tools to probe the architecture of the human mind." - Dillan DiNardo, CEO of Mindstate Design Labs, speaking with Garry Tan in late 2023. #psychedelics #consciousness youtu.be/Tzw6MsmJNAU?si…

The Shulgin Farm is launching a funding campaign to preserve and open the property as a cultural center. The Farm is truly a physical, intellectual, and spiritual landmark of major societal significance, and I'm glad to see it preserved. prweb.com/releases/shulg…

1/ We're thrilled to announce we've received both FDA & EMA approval to begin human trials in the development of our neurotech platform for designing altered states. It’s time to move beyond “psychedelics” and begin the precision design of mood, cognition, and perception. (1/9)

Fantastic piece on the future of psychedelics in TIME from @Jamie_Ducharme. We don't have to accept the unpredictability of popular legacy psychedelics; we should work toward precision-designing modified conscious states. time.com/7027173/new-ps…

🙏🙏🙏 Inspiring words from the legendary Jason Silva!

This company is using AI to engineer new psychedelics. What they create could lead to novel therapies and better our understanding of consciousness. Dillan DiNardo Mindstate Design Labs

🚀 MEET THE #2025OMA COHORT:⁠ Mindstate Design Labs Mindstate Design Labs is a techbio platform & psychiatric therapeutics company that is repurposing the mechanisms of #psychedelics to deliver transient psychoactive states & targeted reintegrations of neural connectivity.